Panel: The Entrepreneur's Journey

​OVERVIEW

​Join SOSV's IndieBio, Catalytic Impact Foundation (CIF), and Orrick on Monday, September 30th for a panel discussion on the entrepreneur's journey.

​Following the panel, there will be general networking & drinks/light snacks. ​

​PANEL

• ​Emily Stern, M.D. – Ceretype Neuromedicine, CEO & Co-Founder 

• ​Ellington West - Sonavi Labs, CEO & Co-Founder

• ​Moderated by Stephen Thau, Orrick, Herrington & Sutcliffe LLP, Partner, Co-Head of Life Sciences Practice

​​ABOUT THE HOSTS

​Catalytic Impact Foundation (CIF): The Catalytic Impact Foundation (CIF) invests philanthropic capital to support companies with transformative, life-sustaining technologies, employing the discipline of traditional venture capital. CIF is focused on funding companies that address unmet medical needs. The fund uses an evergreen model. Returns go back into the fund to be recycled for more impact.

​SOSV: SOSV is a global, multi-stage venture capital firm that operates early stage startup development programs, IndieBio and HAX. SOSV’s core mission is to fund visionary, deep tech founders who will have a profound impact in the areas of human and planetary health.

​Orrick, Herrington & Sutcliffe LLP: Orick is a life sciences and technology focused law firm passionate about helping entrepreneurs, innovators and investors succeed. Top 5 for venture capital globally, Orrick knows the tech ecosystem. Over 4,000 companies worldwide rely on the Orrick team as they scale – turning to them for holistic solutions for day-to-day questions from regulatory, financing, privacy, ESG and IP. When it’s time to exit, Orrick's clients are ready for effective execution and whatever is next. Recognizing Orrick's focus on data and rethinking service delivery, Financial Times has named them among the top 3 most innovative law firms in each of the past seven years.